These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 12400570)
61. [All proton pump inhibitors are equally efficacious in standard dosages]. Hellström PM; Vitols S Lakartidningen; 2003 Jun; 100(25):2212-6. PubMed ID: 12872509 [TBL] [Abstract][Full Text] [Related]
62. [Drug of the month. Lansoprazole (DakaR)]. Scheen AJ Rev Med Liege; 1995 Mar; 50(3):133-4. PubMed ID: 7724943 [No Abstract] [Full Text] [Related]
63. [Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office]. Dohmen W; Fuchs W MMW Fortschr Med; 2005 Apr; 147 Suppl 1():21-5. PubMed ID: 16739368 [TBL] [Abstract][Full Text] [Related]
64. [A clinical trial of lansoprazole in the treatment of duodenal ulcer]. Pei Y; Wang B; Chen S Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):606-8. PubMed ID: 8697927 [TBL] [Abstract][Full Text] [Related]
65. Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori. Chahine C; Moukhachen O; Chedid M; Araj GF; Sharara AI Am J Health Syst Pharm; 2001 Oct; 58(19):1819-23. PubMed ID: 11596697 [TBL] [Abstract][Full Text] [Related]
66. Clinical efficacy of lansoprazole-amoxicillin treatment in eradicating Helicobacter pylori: evaluation by the polymerase chain reaction method. Shimada T; Ogura K; Ota S; Terano A J Clin Gastroenterol; 1995; 20 Suppl 2():S100-3. PubMed ID: 7594321 [TBL] [Abstract][Full Text] [Related]
67. Patent expiration for lansoprazole. Vermeulen LC; Hoffman JM; Shah ND Am J Health Syst Pharm; 2004 Nov; 61(21):2253. PubMed ID: 15552630 [No Abstract] [Full Text] [Related]
68. A novel option in proton pump inhibitor dosing: lansoprazole orally disintegrating tablet dispersed in water and administered via nasogastric tube. Freston JW; Kukulka MJ; Lloyd E; Lee C Aliment Pharmacol Ther; 2004 Aug; 20(4):407-11. PubMed ID: 15298634 [TBL] [Abstract][Full Text] [Related]
69. A novel option for dosing of proton pump inhibitors: dispersion of lansoprazole orally disintegrating tablet in water via oral syringe. Gremse DA; Donnelly JR; Kukulka MJ; Lloyd E; Lee C Aliment Pharmacol Ther; 2004 Jun; 19(11):1211-5. PubMed ID: 15153174 [TBL] [Abstract][Full Text] [Related]
70. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report]. Córdova-Villalobos JA; Ramírez-Barba EJ; Ramírez-Covarrubias JC Rev Gastroenterol Mex; 1996; 61(4):306-9. PubMed ID: 9072780 [TBL] [Abstract][Full Text] [Related]
72. On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole. Johnsson F; Moum B; Vilien M; Grove O; Simren M; Thoring M Scand J Gastroenterol; 2002 Jun; 37(6):642-7. PubMed ID: 12126240 [TBL] [Abstract][Full Text] [Related]
73. [Lansoprazole--profile of a new proton pump inhibitor]. Seifert E Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467 [TBL] [Abstract][Full Text] [Related]
75. Medication errors. Liquid lansoprazole: gumming up the works. Michael RC Nursing; 2002 Oct; 32(10):14. PubMed ID: 12400570 [No Abstract] [Full Text] [Related]
76. Delivery of omeprazole and lansoprazole granules through a nasogastric tube in vitro. Dunn A; White CM; Reddy P; Quercia RA; Chow MS Am J Health Syst Pharm; 1999 Nov; 56(22):2327-30. PubMed ID: 10582827 [No Abstract] [Full Text] [Related]
77. Omeprazole and lansoprazole suspensions for nasogastric administration. McAndrews KL; Eastham JH Am J Health Syst Pharm; 1999 Jan; 56(1):81. PubMed ID: 10048885 [No Abstract] [Full Text] [Related]